Tempest Therapeutics Inc (TPST)

12:15 PM

[EFFECT] Tempest Therapeutics, Inc. SEC Filing - Stock Titan

12:15 PM

Apr 03, 2026

Tempest Therapeutics, Inc. announced that it has received $1.999539 million in funding from Factor Bioscience Inc. and other investors - marketscreener.com

Apr 03, 2026

Apr 03, 2026

TPST Should I Buy - Intellectia AI

Apr 03, 2026

Apr 02, 2026

Tempest Therapeutics (TPST) grants 22,000 stock options to Corporate Controller - Stock Titan

Apr 02, 2026

Apr 02, 2026

Tempest Therapeutics (TPST) CFO receives 140,000 stock options at $1.64 - Stock Titan

Apr 02, 2026

Apr 02, 2026

Versant funds report lower Tempest Therapeutics (TPST) ownership levels - Stock Titan

Apr 02, 2026

Apr 02, 2026

Biopharmaceutical company Tempest Therapeutics Inc (TPST) recently filed a prospectus with the U.S. Securities and Exchange Commission, planning to issue up to approximately 2.8 million common shares through resale, including related warrants. - Bitget

Apr 02, 2026

Apr 02, 2026

Tempest Therapeutics (NASDAQ: TPST) registers 2.78M resale shares from private placement - stocktitan.net

Apr 02, 2026

Apr 02, 2026

According to a filing submitted to the US Securities and Exchange Commission (SEC), Tempest Therapeutics Inc. will not receive any proceeds from the sale of the company's shares by selling shareholders. - Bitget

Apr 02, 2026

Apr 02, 2026

TPST Forecast, Price Target & Analyst Ratings | TEMPEST THERAPEUTICS INC (NASDAQ:TPST) - ChartMill

Apr 02, 2026

Apr 01, 2026

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Tempest Therapeutics (TPST) - The Globe and Mail

Apr 01, 2026

Mar 31, 2026

H.C. Wainwright Maintains Tempest Therapeutics(TPST.US) With Buy Rating, Maintains Target Price $11 - moomoo.com

Mar 31, 2026

Mar 31, 2026

TPST Q4'25 Earnings: EPS estimate is (0.62) USD - TradingView

Mar 31, 2026

Mar 30, 2026

According to the latest filing disclosed by the SEC, existing shareholders of biopharmaceutical company Tempest Therapeutics Inc. plan to resell up to 8.27 million shares of the company's common stock. - Bitget

Mar 30, 2026

Mar 30, 2026

Tempest Therapeutics (NASDAQ: TPST) registers 8.27M shares for resale by sellers - Stock Titan

Mar 30, 2026

Mar 30, 2026

Scienture Holdings Inc (MEDS) Reports FY2025 Earnings - AlphaStreet

Mar 30, 2026

Mar 30, 2026

Tempest Reports Year End 2025 Financial Results and Provides Business Update - bitget.com

Mar 30, 2026

Mar 30, 2026

Tempest reports year end 2025 financial results and provides business update - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Tempest Therapeutics, Inc. (TPST) Reports FY2025 Earnings - AlphaStreet

Mar 30, 2026

Mar 30, 2026

Tempest Therapeutics 2026 10-K: Pipeline Overview, CAR-T & Small Molecule Oncology Strategies, Key Partnerships, and Competitive Position - Minichart

Mar 30, 2026

Mar 30, 2026

Tempest Therapeutics 2025 Loss/Shr $6.33 >TPST - Moomoo

Mar 30, 2026

Mar 30, 2026

Tempest's new CEO arrives as six myeloma patients hit complete response - Stock Titan

Mar 30, 2026

Mar 30, 2026

Tempest Therapeutics 10-K: Net loss $26.3M, EPS $(6.33) - TradingView

Mar 30, 2026

Mar 30, 2026

Tempest Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Tempest Therapeutics (NASDAQ: TPST) advances dual CAR-T and liver cancer drug strategy - Stock Titan

Mar 30, 2026

Mar 30, 2026

Tempest Therapeutics (NASDAQ: TPST) details 2025 loss and CAR-T pipeline gains - Stock Titan

Mar 30, 2026

Mar 25, 2026

Angel Matthew, CEO and president, buys Tempest Therapeutics shares for $500k - Investing.com Australia

Mar 25, 2026

Mar 25, 2026

Tempest Therapeutics Insider Bought Shares Worth $500,001, According to a Recent SEC Filing - Moomoo

Mar 25, 2026

Mar 25, 2026

Matthew Angel’s 37.4% Tempest (NASDAQ: TPST) stake tied to asset deal, private placement - Stock Titan

Mar 25, 2026

Mar 25, 2026

Factor Bioscience tied to Tempest (NASDAQ: TPST) CEO buys 231,482 shares - Stock Titan

Mar 25, 2026

Mar 25, 2026

TPST SEC FilingsTempest Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 25, 2026

Mar 25, 2026

Downgrade Watch: Can Tempest Therapeutics Inc reach all time highs this yearRate Hike & Daily Profit Focused Screening - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

Aug Macro: Will Tempest Therapeutics Inc stock recover after earningsMarket Trend Review & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

TPST Q4'25 Earnings: revenue estimate is 0 USD - TradingView

Mar 25, 2026

Mar 25, 2026

Tempest Therapeutics (TPST) Projected to Post Quarterly Earnings on Wednesday - Defense World

Mar 25, 2026

Mar 24, 2026

Tempest Therapeutics Announces Private Placement Financing Agreement - The Globe and Mail

Mar 24, 2026

Mar 24, 2026

Tempest Therapeutics raises $2 million in private placement By Investing.com - Investing.com Canada

Mar 24, 2026

Mar 23, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 23, 2026

Mar 23, 2026

Tempest Therapeutics Announces $2 Million Private Placement and Securities Purchase Agreement with Institutional and Strategic Investors - Minichart

Mar 23, 2026

Mar 23, 2026

Tempest Therapeutics raises $2 million in private placement - Investing.com

Mar 23, 2026

Mar 23, 2026

Tempest Therapeutics Raises $2.0 Million in Private Placement With Warrants Priced at $2.16 - TradingView

Mar 23, 2026

Mar 23, 2026

Tempest Therapeutics (Nasdaq: TPST) details $2.0 million private placement deal - Stock Titan

Mar 23, 2026

Mar 23, 2026

Tempest Therapeutics Announces Up To $6 Million Private Placement - Bitget

Mar 23, 2026

Mar 23, 2026

Tempest Therapeutics Inc expected to post a loss of 62 cents a shareEarnings Preview - TradingView

Mar 23, 2026

Mar 22, 2026

Technical Analysis: Is Tempest Therapeutics Inc exposed to political risk2026 Growth vs Value & Capital Protection Trade Alerts - baoquankhu1.vn

Mar 22, 2026

Mar 21, 2026

Aug Final Week: Is Tempest Therapeutics Inc stock a value trap2026 Retail & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

Is Tempest Therapeutics Inc stock a value trapWeekly Profit Analysis & Long Hold Capital Preservation Plans - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

Whats the MACD signal for Tempest Therapeutics IncMarket Volume Summary & Low Drawdown Momentum Ideas - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

Tempest Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | | US87978U2078 - marketscreener.com

Mar 21, 2026

Mar 19, 2026

Tempest Therapeutics, Inc. announced that it expects to receive $2 million in funding - marketscreener.com

Mar 19, 2026

Mar 16, 2026

Aug Fed Impact: Is Tempest Therapeutics Inc gaining market shareCEO Change & Safe Entry Point Identification - baoquankhu1.vn

Mar 16, 2026

Mar 16, 2026

Exit Recap: Is Tempest Therapeutics Incs growth already priced in2026 Reactions & Real-Time Chart Pattern Alerts - baoquankhu1.vn

Mar 16, 2026

Mar 11, 2026

Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026 - Bitget

Mar 11, 2026

Mar 11, 2026

Tempest Therapeutics Inc. (referred to as Tempest) recently disclosed a strategic collaboration regarding its core candidate drug Tpst-2003. - Bitget

Mar 11, 2026